The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Open accessThe DOI matches its Crossref record; 280 of the 282 references it cites were found in a registry or an index.
Abstract
The mammalian HSP90 family of proteins is a cluster of highly conserved molecules that are involved in myriad cellular processes. Their distribution in various cellular compartments underlines their essential roles in cellular homeostasis. HSP90 and its co-chaperones orchestrate crucial physiological processes such as cell survival, cell cycle control, hormone signaling, and apoptosis. Conversely, HSP90, and its secreted forms, contribute to the development and progress of serious pathologies, including cancer and neurodegenerative diseases. Therefore, targeting HSP90 is an attractive strategy for the treatment of neoplasms and other diseases. This manuscript will review the general structure, regulation and function of HSP90 family and their potential role in pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 The mechanism of protein folding by HSP90 [44]. (I) The client protein either mis-folded protein or nascent polypeptide is bound by Hsp70/Hsp40/ADP complex to be protected from potential aggregation [102]; (II) The protein complex formed is further stabilized by Hsp70-interacting protein (HIP) or Bcl2 which support the change of ADP to ATP [103]; (III) HSP90 binds the client protein harboured by the Hsp70/Hsp40 protein complex to start its action; (IV) The interaction between HSP90 and HSP70 is facilitated by the adaptor protein, HOP/Sti1 (Hsp90–Hsp70 organizing protein) [104]. Importantly, additional co-chaperone known as Cdc37 (cell-division-cycle 37 homologue) or p50 is needed for loading client kinases onto HSP90 [105]; (V) As the client protein is loaded, other co-chaperones, immunophilins like (FKBP51, FKBP52) are added to the HSP90 homodimer forming an activated heteroprotein complex while the HSP70, HIP and HOP are released [106]; (VI) Binding of ATP to the NTD of HSP90 in the heteroprotein complex switches the HSP90 from the “open state” to the “closed state” [107]. Various inhibitors of HSP90 can act at this stage by competing with ATP for the NTD binding site consequently resulting in protein degradation by proteasome [101]; (VII) If no inhibitors interfere with the folding cycle, association of other co-chaperones occurs including p23 and Aha1 (activator of Hsp90 ATPase homologue 1); (VIII) Binding of Aha1, not shown in the diagram, to the MD of HSP90 induces ATP hydrolysis and supports folding of the bound client, as well as enhances the release of immunophilins and co-chaperones [96].](https://figures.cochat.ai/paper-figures/ca152a6f8c074a578788e2a838e5bbeb/the-hsp90-family-structure-regulation-function-and-implications-in-health-and-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It supports the stability and function of numerous oncoproteins, thereby facilitating tumor growth, survival, and resistance to therapies [19, 20].”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lindquist, S. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.005443 · Cited by 4,588 · cited 1×
“This response is a common physiological process among almost all living organisms and includes alterations in the gene expression profile through increased HSP expression [3].”
BackgroundMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 2×
“In addition, increased ROS, calcium, and diminished ATP following stress conditions cause activation of Cyp-D which, in turn, modulate the conformation of PT pore proteins and consequently generate non-selective pores through the membrane [177,182,183].”
BackgroundHSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502 · cited 2×
“They exist in all living kingdoms except for archaea [6] and represent about 1–2% of the total mammalian cellular proteins under non-stress conditions [7].”
BackgroundA new puffing pattern induced by temperature shock and DNP in drosophila
Ritossa, F. (1962) · Experientia · doi:10.1007/bf02172188 · Cited by 2,068 · cited 1×
“In the laboratory of Italian scientist Ferruccio Ritossa [1], He examined flies, Drosophila melanogaster, that were left un-intentionally at an elevated temperature, and noticed a characteristic puffing in the chromosomes.”
BackgroundInnate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899 · cited 1×
“Following viral infections, activated TLRs, trigger several signaling events resulting in production of type I interferons, inflammatory cytokines, and chemokines ultimately leading to eliminating an invading pathogen [243].”
BackgroundNakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635 · cited 1×
“Critically, the mitochondrial matrix protein, cyclophilin D (Cyp-D), was found to play a key role in the pore formation of the mitochondrial inner membrane [181].”
BackgroundSchopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540 · cited 9×
“disease HSP90 appeared to promote the hyper phosphorylation of tau protein (tau-p) via activation of kinases leading to the formation of neurofibrillary tangles [63,198].”
BackgroundInfluentialGuidelines for the nomenclature of the human heat shock proteins
Kampinga, H. H., Hageman, J., Vos, M. J., Kubota, H., Tanguay, R. M., Bruford, E. A., Cheetham, M. E., Chen, B., & Hightower, L. E. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0068-7 · Cited by 1,360 · cited 5×
“HSP90 proteins can be classified according to their cellular localization, where cytoplasmic members include HSPC1 (HSP 90-alpha), HSPC2 (HSP 90-alpha A2), and HSPC3 (HSP 90-beta), ER resident member; HSPC4 or GRP94 (GP96), and mitochondrial localized member; and HSPC5 (TRAP1).”
BackgroundMethodInfluentialBasu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,305 · cited 2×
“Earlier investigations reported that GRP94 can be released outside the cells where its secretion was associated with severe tissue damage and necrotic cell death [163,164].”
BackgroundThe ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., & Wallace, D. C. (2004) · Nature · doi:10.1038/nature02229 · Cited by 1,086
Cited by
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Hu, C., Yang, J., Qi, Z., Wu, H., Wang, B., Zou, F., Mei, H., Liu, J., Wang, W., & Liu, Q. (2022) · MedComm · doi:10.1002/mco2.161 · Cited by 779
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
Birbo, B., Madu, E. E., Madu, C. O., Jain, A., & Lu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910317 · Cited by 244
“Their prominent role lies in proteostasis, cell differentiation, and development [2].”
BackgroundInfluentialRedox toxicology of environmental chemicals causing oxidative stress
Zheng, F., Gonçalves, F. M., Abiko, Y., Li, H., Kumagai, Y., & Aschner, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101475 · Cited by 191
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
Li, Z.-N., & Luo, Y. (2022) · Oncology Reports · doi:10.3892/or.2022.8443 · Cited by 173
“The HSP90 family, which are highly conserved molecules, are involved in the regulation of the folding of newly synthesized proteins, as well as in correcting incorrectly folded proteins and impeding the aggregation of incorrectly folded proteins (2).”
Zhou, C., Yu, T., Zhu, R., Lu, J., Ouyang, X., Zhang, Z., Chen, Q., Li, J., Cui, J., Jiang, F., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.77979 · Cited by 179
“HSP90 plays a significant role in essential cellular processes and regulatory pathways such as apoptosis, cell cycle control, cell signaling, cell viability, protein folding, and degradation, as they interact with client proteins and co-chaperones [43].”
BackgroundWan, Q., Song, D., Li, H., & He, M.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00233-4 · Cited by 165
“3) TRAP1 (HSPC5) locates in mitochondria.(12) Among them, Hsp90α and Hsp90β account for the greatest proportion in humans.”
BackgroundAn update on the status of HSP90 inhibitors in cancer clinical trials
Rastogi, S., Joshi, A., Sato, N., Lee, S., Lee, M.-J., Trepel, J. B., & Neckers, L. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.05.005 · Cited by 139
HSP90 mediates the connection of multiple programmed cell death in diseases
Peng, C., Zhao, F., Li, H., Li, L., Yang, Y., & Liu, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05373-9 · Cited by 129
“In general, there are four isoforms of HSP90 in cells which involves in various cellular functions, including HSP90α and HSP90β in the cytoplasm, tumor necrosis factor receptorassociated protein-1 (TRAP1) in the mitochondria and the glucose regulated protein 94 in the endoplasmic reticulum [8].”
BackgroundInfluentialHeat shock protein 90: biological functions, diseases, and therapeutic targets
Wei, H., Zhang, Y., Jia, Y., Chen, X., Niu, T., Chatterjee, A., He, P., & Hou, G. (2024) · MedComm · doi:10.1002/mco2.470 · Cited by 131
“8,9 Through these functions, HSP90 facilitates the expression of genetic variants in its client proteins, thereby enhancing an organism’s ability to adapt and survive in stressful environments.”
BackgroundInfluentialExtracellular heat shock proteins and cancer: New perspectives
Albakova, Z., Siam, M. K. S., Sacitharan, P. K., Ziganshin, R., Ryazantsev, D. Y., & Sapozhnikov, A. M. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100995 · Cited by 122
Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment
Yang, S., Xiao, H., & Cao, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112074 · Cited by 121
Zuo, W., Pang, Q., Zhu, X., Yang, Q., Zhao, Q., He, G., Han, B., & Huang, W. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01601-1 · Cited by 113
Condelli, V., Crispo, F., Pietrafesa, M., Lettini, G., Matassa, D. S., Esposito, F., Landriscina, M., & Maddalena, F. (2019) · Cells · doi:10.3390/cells8060532 · Cited by 104
“Members of the HSP90 family (molecular weight of about 90kDa) are highly conserved molecules that promote the folding of neo-synthesized or incorrectly folded proteins, and block their aggregation [24].”
BackgroundShi, W. L., Feng, L., Dong, S., Ning, Z., Hua, Y., Liu, L., Chen, Z., & Meng, Z. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00604-y · Cited by 107
The potential role of hydrogen sulfide in cancer cell apoptosis
Gao, W., Liu, Y., Zhang, Y.-X., Wang, Y., Jin, Y., Yuan, H., Liang, X., Ji, X., Jiang, Q., & Wu, D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01868-w · Cited by 93
“The heat shock protein HSP90 acts as a molecular chaperone that promotes the folding of ab initio synthesized or misfolded proteins, relieves the stress of UPRs in the ER, and promotes cell survival [55].”
BackgroundProtein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
Nakamura, T., Oh, C.-K., Zhang, X., & Lipton, S. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.002 · Cited by 88
Selective Inhibition of the Hsp90α Isoform
Mishra, S. J., Khandelwal, A., Banerjee, M., Balch, M., Peng, S., Davis, R. E., Merfeld, T., Munthali, V. Y., Deng, J., Matts, R. L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202015422 · Cited by 83
Advances in the structures, mechanisms and targeting of molecular chaperones
Gu, J., He, Y., He, C., Zhang, Q., Huang, Q., Bai, S., Wang, R., You, Q., & Wang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02166-2 · Cited by 85
“383,384 In early clinical trials, many inhibitors were mainly used as single agent in various cancer types.”
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“A link between intraneuronal tau 19,98 and α-synuclein deposition 123 and senescence has been established.”
Research progress in inducing immunogenic cell death of tumor cells
Xie, D., Wang, Q., & Wu, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1017400 · Cited by 82
Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
Zhang, J., Li, H., Liu, Y., Zhao, K., Wei, S., Sugarman, E. T., Liu, L., & Zhang, G. (2022) · Cells · doi:10.3390/cells11182778 · Cited by 81
“It is worth mentioning that TRAP1 has been regarded as another version of HSP90— namely, mitochondrial HSP90—because it shares 60% of its sequence with HSP90 and contains the same domains: NTD, ND, and CTD [32,95].”
BackgroundInhibitors of HSP90 in melanoma
Mielczarek-Lewandowska, A., Hartman, M. L., & Czyż, M. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01577-1 · Cited by 78
Jee, B., Dhar, R., Singh, S. K., & Karmakar, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648463 · Cited by 80
Cellular and Molecular Adaptation of Arabian Camel to Heat Stress
Hoter, A., Rizk, S. E., & Naim, H. Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00588 · Cited by 76
Self-citationLee, Y., Fong, S. Y., Shon, J. H., Zhang, S., Brooks, R. C., Lahens, N. F., Chen, D., Dang, C. V., Field, J. M., & Sehgal, A. (2021) · Science Advances · doi:10.1126/sciadv.abd2645 · Cited by 74
“Although mammalian Hsp90AA1 and Hsp90AB1 have similar structure and cytosolic expression, Hsp90AA1 is induced by external cues to enhance oncogenic signaling responses and cell cycle progression, while Hsp90AB1 is expressed constitutively, mostly for cellular maintenance (24).”
BackgroundInfluentialSmall molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
“As a molecular chaperone with five subtypes, including Hsp90A, Hsp92B, Hsp90C, TRAP, and HTPG, it is involved in the maturation of various client proteins and is related to several human disorders 103,104 .”
BackgroundHeat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
Hoter, A., & Naim, H. Y. (2019) · Cancers · doi:10.3390/cancers11091389 · Cited by 76
“Mammalian HSPs comprise four main HSP90 proteins that have molecular mass of about 90 kDa and resides in different cellular organelles, including the ER, the mitochondria and the cytosol [77].”
BackgroundSelf-citationMitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
Percy, K. C. M., Liu, Z., & Qi, X. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00525 · Cited by 80
“Chaperones such as mtHsp10 [35], mtHsp40 (DNAJ) [36], mtHsp60 [37], mtHsp70 [38, 39], mtHsp90 [40], mtHsp100 [41], and small heat shock proteins (sHsp) [42] recognize and refold misfolded proteins.”
Youssef, M. E., Cavalu, S. D., Hasan, A. M., Yahya, G., Abdel-Dayem, M. A., & Saber, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055014 · Cited by 73
The Relationship between Circadian Rhythm and Cancer Disease
Munteanu, C., Turti, S., Achim, L., Muresan, R., Souca, M., Prifti, E., Mârza, S. M., & Papuc, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115846 · Cited by 76
“However, Hsp90AA1 is constitutively generated, mostly for cellular repair, whereas Hsp90AB1 is activated by external signals to promote oncogenic signaling responses and cell cycle progression [248].”
BackgroundCurrent and Promising Antivirals Against Chikungunya Virus
Hucke, F. I. L., & Bugert, J. J. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.618624 · Cited by 64
The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer
Hoter, A., Rizk, S. E., & Naim, H. Y. (2019) · Cancers · doi:10.3390/cancers11081194 · Cited by 65
“The structural architecture of HSPs has been previously reviewed [38,58,59].”
BackgroundSelf-citationTargeting HSF1 for cancer treatment: mechanisms and inhibitor development
Chin, Y., Gumilar, K. E., Li, X., Tjokroprawiro, B. A., Lu, C., Lu, J., Zhou, M., Sobol, R. W., & Tan, M. (2023) · Theranostics · doi:10.7150/thno.82431 · Cited by 62
“After the cycle is completed, the original client proteins are transformed into mature and functional proteins [41].”
Heat Shock Proteins and Ferroptosis
Liu, Y., Zhou, L., Xu, Y., Li, K., Zhao, Y., Qiao, H., Xu, Q., & Zhao, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.864635 · Cited by 67
Parma, B., Wurdak, H., & Ceppi, P. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100888 · Cited by 64
“HSPA9, and HSPA5) are constitutively expressed in cells, and their expression is regulated by physiological conditions, such as cell cycle, differentiation, and apoptosis, subsequently contributing to the regulation of these processes (Jolly and Morimoto, 2000; Hoter et al., 2018).”
BackgroundZhou, H., Wu, C., Jin, Y., Wu, O., Chen, L., Guo, Z., Xinzhou, W., Chen, Q., Kwan, K. Y.-H., Li, Y. M., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.08.016 · Cited by 80
“However, oxidative stress-induced impairment of mitochondrial function negatively affects the function of HSPs [111,112].”
BackgroundHeat shock protein 60 and cardiovascular diseases: An intricate love‐hate story
Krishnan‐Sivadoss, I., Mijares-Rojas, I. A., Villarreal-Leal, R. A., Torre‐Amione, G., Knowlton, A. A., & Guerrero-Beltrán, C. E. (2020) · Medicinal Research Reviews · doi:10.1002/med.21723 · Cited by 61
Alberti, G., Vergilio, G., Paladino, L., Barone, R., Cappello, F., de Macario, E. C., Macario, A. J. L., Bucchieri, F., & Rappa, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147792 · Cited by 60
“The four members reside in the following cell compartments: (i) Hsp90 alpha and Hsp90 beta are found in the cytosol; (ii) Grp94 (94 kDa glucose-regulated protein) resides in the endoplasmic reticulum; and (iii) TRAP-1 (tumor necrosis receptor-associated protein 1) is localized in the mitochondria [5,83,84].”
BackgroundApigenin suppresses influenza A virus‐induced RIG‐I activation and viral replication
Xu, X., Miao, J., Shao, Q., Gao, Y., & Hong, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26403 · Cited by 57
“chaperones that prevent protein aggregation and degradation, as well as refold denatured or unfolded proteins via their ATPase activity.(46) It has been reported that Hsp90α modulates the activity of RIG‐I and shields it from proteasomal degradation.”
BackgroundPupa, S. M., Ligorio, F., Cancila, V., Franceschini, A., Tripodo, C., Vernieri, C., & Castagnoli, L. (2021) · Cancers · doi:10.3390/cancers13194778 · Cited by 62
Hsp90: From Cellular to Organismal Proteostasis
Somogyvári, M., Khatatneh, S., & Sőti, C. (2022) · Cells · doi:10.3390/cells11162479 · Cited by 58
“The chaperone cycle of Hsp90 helps fold and stabilize its client proteins [7].”
BackgroundDernovšek, J., & Tomašič, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108396 · Cited by 58
Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to Overcoming
Klabukov, I., Kabakov, A. E., Yakimova, A. O., Baranovskii, D., Сосин, Д. В., Atiakshin, D., Ignatyuk, M. A., Yatsenko, E., Rybachuk, V. A., Evstratova, E. S., et al. (2025) · Current Oncology · doi:10.3390/curroncol32020079 · Cited by 55
“In turn, HSP90 is one of the key chaperones and regulators of intracellular signaling [49]; in addition, some HSP90 molecules are transported by the cell into the extracellular space (the so-called extracellular HSP90 or eHSP90).”
Kunachowicz, D., Król-Kulikowska, M., Raczycka, W., Sleziak, J., Błażejewska, M., & Kulbacka, J. (2024) · Cancers · doi:10.3390/cancers16081500 · Cited by 54
“The hydrolysis of ATP and the following replacement with ADP results in the release of stabilized and activated client proteins and the return of Hsp90 to its original conformation [171].”
BackgroundTherapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis
Tseng, J., Chang, Y.-C., Huang, C., Hsu, L.-C., & Chuang, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071064 · Cited by 56
Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment
Zhang, J., Gao, Y., Zhang, Z., Zhao, J., Jia, W., Xia, C., Wang, F., & Liu, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01352 · Cited by 49
Extracellular heat shock proteins in neurodegenerative diseases: New perspectives
Lyon, M. S., & Milligan, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134462 · Cited by 45
Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases
Tukaj, S., & Sitko, K. (2022) · Biomolecules · doi:10.3390/biom12081153 · Cited by 55
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
Liang, X., Chen, R., Wang, C., Wang, Y., & Zhang, J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00966 · Cited by 51
Heat shock proteins-driven stress granule dynamics: yet another avenue for cell survival
Verma, A., Sumi, S., & Seervi, M. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01678-w · Cited by 52
“Contrastingly, HSP90β gene is constitutively expressed at a notable level but weakly inducible by a heat shock [60].”
BackgroundAdvances towards Understanding the Mechanism of Action of the Hsp90 Complex
Prodromou, C., & Bjorklund, D. M. (2022) · Biomolecules · doi:10.3390/biom12050600 · Cited by 52
Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective
Patel, V. K., Shirbhate, E., Tiwari, P., Kore, R., Veerasamy, R., Mishra, A., & Rajak, H. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220922105615 · Cited by 47
Chakraborty, A., Mohapatra, S. S., Barik, S., Roy, I., Gupta, B., & Biswas, A. (2023) · Bioscience Reports · doi:10.1042/bsr20220324 · Cited by 53
Premji, T. P., Dash, B. S., Das, S., & Chen, J. (2024) · Nanomaterials · doi:10.3390/nano14010112 · Cited by 48
McDaniels, J. M., Shetty, A. C., Kuscu, C., Kuscu, C., Bardhi, E., Rousselle, T. V., Drachenberg, C., Talwar, M., Eason, J. D., Muthukumar, T., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.02.018 · Cited by 50
TRAP1 in Oxidative Stress and Neurodegeneration
Ramos Rego, I., Santos Cruz, B., Ambrósio, A. F., & Alves, C. H. (2021) · Antioxidants · doi:10.3390/antiox10111829 · Cited by 44
“TRAP1 has an N-terminus 59 amino acid sequence serving as mitochondrial targeting that is cleaved off upon the protein being translocated to the mitochondria [10,16].”
BackgroundThe chaperone system in cancer therapies: Hsp90
Basset, C. A., de Macario, E. C., Leone, L. G., Macario, A. J. L., & Leone, A. (2023) · Journal of Molecular Histology · doi:10.1007/s10735-023-10119-8 · Cited by 45
“…in human) and the heat-shock inducible isoform Hsp82 (Hsp90α in human), while humans have two extra organellespecific isoforms: TRAP1 is confined in the mitochondrial matrix and intermembranous space and GRP94 resides in the endoplasmic reticulum (ER) (Hoter et al. 2018b; Biebl and Buchner 2019).”
BackgroundInfluentialCell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
Kim, J. W., Cho, Y. B., & Lee, S. (2021) · Cells · doi:10.3390/cells10030670 · Cited by 45
Nanomaterial-mediated low-temperature photothermal therapy via heat shock protein inhibition
Yu, X., Sun, Z., Liu, J., Li, W., Wang, M., Chu, Y., Sun, Z., & Deng, G. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1027468 · Cited by 43
“HSP 90 is a highly conserved ATP-dependent heat stress protein with increased expression during cellular stress and can correct protein misfolding to maintain its activity and reduce cellular damage (Hong et al., 2013; Hoter et al., 2018).”
BackgroundZhou, Y., She, R., Mei, Z., Liu, D., & Ge, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155399 · Cited by 43
Hoter, A., & Naim, H. Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215331 · Cited by 44
Self-citationNatural resorcylic acid lactones: A chemical biology approach for anticancer activity
Kuttikrishnan, S., Prabhu, K. S., Sharie, A. H. A., Zu’bi, Y. O. A., Alali, F. Q., Oberlies, N. H., Ahmad, A., El‐Elimat, T., & Shahab Uddin, M. S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.001 · Cited by 42
Zhang, H., Yin, X., Zhang, X., Zhou, M., Xu, W., Wei, Z., Song, C., Han, S., & Han, W. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221118202 · Cited by 40
“14–16 In mammalian cells, HSP90 has 4 subtypes: heat shock protein 90 alpha family class A member 1 (HSP90AA1), heat shock protein 90 alpha family class B member 1 (HSP90AB1), glucose-regulated protein 94 (GRP94), and TNF receptorassociated protein 1 (TRAP1).(17) Previous studies mainly focused on HSP90 as a whole, an…”
BackgroundSon, H., Choi, H.-S., Baek, S. E., Kim, Y. H., Hur, J., Han, J.-H., Moon, J. H., Lee, G. S., Park, S. G., Woo, C.-H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114566 · Cited by 43
Nie, Z., Xiao, C., Wang, Y., Li, R., & Zhao, F. (2024) · Biomarker Research · doi:10.1186/s40364-024-00664-z · Cited by 42
“Through transcriptional regulation, posttranslational modifications, and interaction with co-chaperones, HSP90’s function is finely tuned to maintain cellular homeostasis and respond to stress conditions effectively [24].”
BackgroundPan, T., Yu, Z., Jin, Z., Wu, X., Wu, A., Hou, J., Chang, X., Fan, Z., Li, J., Yu, B., et al. (2021) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2021.02.003 · Cited by 38
“Hsp90a is known as a molecular chaperone that is essential for maintaining the proper folding and stability of specific target proteins (Hsp90 clients).(21) We therefore performed co-immunoprecipitation (Co-IP) analysis with Hsp90a-specific antibody to evaluate binding affinity alterations of Hsp90a and its potential…”
MethodForghani, P., Rashid, A., Sun, F., Liu, R., Li, D., Lee, M. R., Hwang, H., Maxwell, J. T., Mandawat, A., Wu, R., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022247 · Cited by 39
A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and BeyondPreprint
Taldone, T., Wang, T., Rodina, A., Pillarsetty, N., Digwal, C. S., Sharma, S., Yan, P., Joshi, S., Pagare, P. P., Bolaender, A., et al. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034116 · Cited by 40
“We have also learned how specific chaperome functions are being altered in the context of disease (Woodford et al. 2016b; Boland et al. 2018; Hoter et al. 2018; Joshi et al. 2018; Kropski and Blackwell 2018; RodríguezIturbe and Johnson 2018; Yakubu and Morano 2018).”
BackgroundHeat shock proteins and the calcineurin-crz1 signaling regulate stress responses in fungi
Roy, A., & Tamuli, R. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02833-w · Cited by 40
“In mammals, Hsp90 is involved in cell cycle regulation, hormone signaling, apoptosis, cancer, and neurodegenerative diseases (Hoter et al. 2018).”
BackgroundAdvances in Brain Tumor Therapy Based on the Magnetic Nanoparticles
Xu, S., Zhang, G., Zhang, J., Liu, W., Wang, Y., & Fu, X. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s444319 · Cited by 39
Tu, Y., Dai, G., Chen, Y., Tan, L., Liu, H., & Chen, M. (2025) · Exploration · doi:10.1002/exp.20240247 · Cited by 44
“HSP90 α (HSP90AA1) and HSP90 β (HSP90AB1) are key members of the heat shock protein (HSP) family, involved in various physiological processes, with their malfunction closely associated with the progression of numerous diseases such as cancer and neurodegenerative diseases [76].”
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
Falcone, I., Conciatori, F., Bazzichetto, C., Bria, E., Carbognin, L., Malaguti, P., Ferretti, G., Cognetti, F., Milella, M., & Ciuffreda, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228419 · Cited by 39
“Heat-shock protein 90 (HSP90), for example, is a molecular chaperonin which modulates the maturation and stabilization of many “client” proteins, such as AXL receptor (Figure 2C) [48,49].”
BackgroundPeng, J., Xie, F., Qin, P., Liu, Y., Niu, H., Sun, J., Xue, H., Zhao, Q., Liu, J., & Wu, J. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106622 · Cited by 38
The biology and inhibition of glucose‐regulated protein 94/gp96
Pugh, K. W., Alnaed, M., Brackett, C. M., & Blagg, B. S. J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21915 · Cited by 37
Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing
Dabravolski, S. A., Sukhorukov, V. N., Kalmykov, V. A., Orekhov, N. A., Grechko, A. V., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020649 · Cited by 38
“Upon interaction with misfolded proteins, HSP90 decreases their aggregation with other misfolded proteins, further linking it with protein degradation and destruction (via polyubiquitination and 26S proteasome, respectively) [10].”
BackgroundZhao, Q., Zhu, H.-P., Xie, X., Mao, Q., Liu, Y., He, X., Peng, C. Y., Jiang, Q., & Huang, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051845 · Cited by 37
Rampogu, S. D., Parate, S., Saravanan, P., Park, C., Baek, A., Son, M., Park, Y., Park, S. J., & Lee, K. W. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107113 · Cited by 36
Yu, X., Mao, M., Liu, X., Shen, T., Li, T., Yu, H., Zhang, J., Chen, X., Zhao, X., & Zhu, D. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01886-y · Cited by 36
The Role of HSP90 Inhibitors in the Treatment of Cardiovascular Diseases
Qi, S., Yi, G., Yu, K., Feng, C., & Deng, S. (2022) · Cells · doi:10.3390/cells11213444 · Cited by 38
“It is associated with protein degradation and destruction [2,32].”
BackgroundInfluentialHeat shock proteins and cancer: The FoxM1 connection
Alimardan, Z., Abbasi, M., Hasanzadeh, F., Aghaei, M., Khodarahmi, G., & Kashfi, K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115505 · Cited by 38
General Structural and Functional Features of Molecular Chaperones
Edkins, A. L., & Boshoff, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78397-6_2 · Cited by 37
Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress
Uddin, M. A., Akhter, M. S., Kubra, K., Whitaker, K. E., Shipley, S. L., Smith, L. M., & Barabutis, N. (2021) · Brain Disorders · doi:10.1016/j.dscb.2020.100001 · Cited by 34
Wu, Y.-W., Chao, M., Tu, H., Chen, L., Hsu, K., Liou, J., Yang, C., Yen, S., HuangFu, W., & Pan, S. (2021) · Oncogenesis · doi:10.1038/s41389-021-00331-0 · Cited by 34
Stofberg, M. L., Caillet, C., de Villiers, M., & Zininga, T. (2021) · Cells · doi:10.3390/cells10112849 · Cited by 34
Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
Ratajczak, W., Lubkowski, M., & Lubkowska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020897 · Cited by 33
“In this process, two C-terminal helices form a four-helix bundle [73].”
BackgroundAlessio, N., Acar, M. B., Squillaro, T., Aprile, D., Ayaz‐Güner, Ş., Bernardo, G. D., Peluso, G., Özcan, S., & Galderisi, U. (2023) · Cell Proliferation · doi:10.1111/cpr.13401 · Cited by 36
“HSP90 proteins are involved in several cellular processes (cell survival, cell-cycle control, hormone signalling and apoptosis) and may play a role in homeostasis, stress response and several pathological conditions.(30) As the senescence process proceeded to a late stage, the composition of secretome changed and othe…”
BackgroundThe roles of molecular chaperones in regulating cell metabolism
Binder, M. J., & Pedley, A. M. (2023) · FEBS Letters · doi:10.1002/1873-3468.14682 · Cited by 34
Brezić, N., Gligorevic, S., Sič, A., & Knežević, N. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040259 · Cited by 32
“For instance, Hsp70 family chaperones use ATP-dependent cycles to stabilize unfolded proteins and give them another chance to fold [24], while Hsp90 often assists in the later stages of folding for signaling proteins and receptors [25].”
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues
Lallier, M., Marchandet, L., Moukengué, B., Charrier, C., Baud’huin, M., Verrecchia, F., Ory, B., & Lamoureux, F. (2021) · Cells · doi:10.3390/cells10040754 · Cited by 30
Manzon, L. A., Zak, M. A., Agee, M., Boreham, D. R., Wilson, J. Y., Somers, C. M., & Manzon, R. G. (2022) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2021.103185 · Cited by 30
Siani, P., & Valentin, C. D. (2022) · Nanoscale · doi:10.1039/d1nr07647g · Cited by 30
Liew, H. Y., Tan, X. Y., Chan, H. H., Khaw, K. Y., & Ong, Y. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106260 · Cited by 30
Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway
Meng, D., Deng, X., Wu, Y., Wu, J., Zhang, Y., Zhang, J., Zhao, Y., & Che, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16960 · Cited by 30
Hu, Y., Li, J., Chen, H., Shi, Y., Ma, X., Wáng, Y., Li, X., Zhong, Q., Wang, Y., Jiang, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202414673 · Cited by 41
Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder
Mazón-Cabrera, R., Vandormael, P., & Somers, V. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01474 · Cited by 32
Saravanakumar, K., Sriram, B., Sathiyaseelan, A., Hu, X., Mariadoss, A. V. A., MubarakAli, D., & Wang, M. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.12.002 · Cited by 29
Liu, L., Deng, Y., Zheng, Z., Deng, Z., Zhang, J., Li, J., Liang, M., Zhou, X., Tan, W., Yang, H., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0215 · Cited by 30
“Unexpectedly, the adverse effects, such as structural instability and hepatotoxicity, have been reported with early Hsp90 inhibitors (5, 6), STA9090 (Ganetespib) is the onlyHsp90 inhibitor, which halted in the clinical trial phase III (7).”
BackgroundThe Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases
Roberts, R. J., Hallee, L., & Lam, C. K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121373 · Cited by 32
“Hsp90α/β operates in the cytosol while Grp94 localizes to the endoplasmic reticulum and TRAP1 to the inner mitochondrial space [7].”
BackgroundLi, Q., Qi, G., Lutter, D., Beard, W. L., Souza, C. R. S., Highland, M. A., Wu, W., Li, P., Zhang, Y., Atala, A., et al. (2022) · Biomolecules · doi:10.3390/biom12091317 · Cited by 32
“Furthermore, abundant intracellular proteins that are not expected to be secreted into the CM, such as EEF1G [81], PLS3 [82], and HSP90AB1 [83], were found in the CM of the Hystem hADMSCs (Figure 4C).”
Background
Metadata
- Authors
- Hoter, A., El-Sabban, M. E., & Naim, H. Y.
- Affiliations
- Cairo University (EG)
- American University of Beirut (LB)
- University of Veterinary Medicine Hannover, Foundation (DE)
- Corresponding author
- Naim, Hassan Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-08-29
- Volume
- 19
- Issue
- 9
- Pages
- 2560
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6164434
- OpenAlex
- W2889502232
- Cited by
- 693
- References
- 282
- Citations by year
- 2026: 67 · 2025: 120 · 2024: 133 · 2023: 98 · 2022: 103 · 2021: 83 · 2020: 57 · 2019: 31 · 2018: 1
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutscher Akademischer Austauschdienst (Scholarship to A.H.)
- American University of Beirut (Intramural funding to M.E.S.)
- Stiftung Tierärztliche Hochschule Hannover (Intramural funding to H.Y.N.)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- HSP90, Hsp90 co-chaperone, molecular chaperones, protein structure, cellular homeostasis, cell survival, cell cycle regulation, hormone signaling, apoptosis, cancer, neurodegenerative diseases
- MeSH terms
- Animals, Cell Cycle, Cell Survival, Humans, Membrane Proteins, Apoptosis, Molecular Chaperones, HSP70 Heat-Shock Proteins, HSP90 Heat-Shock Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.